Why Earnings Season Could Be Great for Vertex Pharmaceuticals (VRTX)Zacks Investment Research • 10/29/21
Vertex Pharmaceuticals (VRTX) Stock Sinks As Market Gains: What You Should KnowZacks Investment Research • 10/26/21
Vertex and Mammoth Biosciences Announce Collaboration to Develop In Vivo Gene-Editing Therapies for Serious DiseasesBusiness Wire • 10/26/21
Can Vertex (VRTX) Climb 42% to Reach the Level Wall Street Analysts Expect?Zacks Investment Research • 10/21/21
Vertex to Present Long-Term Data Demonstrating Significant Benefits of Treatment With CFTR Modulators at North American Cystic Fibrosis Conference (NACFC)Business Wire • 10/19/21
Vertex Announces Positive Day 90 Data for the First Patient in the Phase 1/2 Clinical Trial Dosed With VX-880, a Novel Investigational Stem Cell-Derived Therapy for the Treatment of Type 1 DiabetesBusiness Wire • 10/18/21
Why the Earnings Surprise Streak Could Continue for Vertex (VRTX)Zacks Investment Research • 10/13/21